Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | N/A | 0 | 0 | 0 | 949 |
| Income taxes - deferred | 137 | 28 | 163 | 35 | 1,379 |
| Accounts receivable | -420 | -749 | 316 | 10,841 | 6,098 |
| Other Working Capital | -411 | -493 | -1,671 | 8,176 | 7,064 |
| Other Operating Activity | 484 | 865 | -1,982 | -18,262 | -7,245 |
| Operating Cash Flow | $-210 | $-349 | $-3,175 | $790 | $8,245 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -2 | 23 | 9 | 382 |
| Other Investing Activity | -14 | 68 | 80 | 85 | 181 |
| Investing Cash Flow | $-15 | $66 | $103 | $94 | $563 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | 210 | -11,311 | N/A | N/A | 0 |
| Dividend Paid | N/A | 0 | 0 | 0 | 120 |
| Other Financing Activity | 0 | 0 | -213 | 0 | 0 |
| Financing Cash Flow | $210 | $-11,311 | $-213 | $0 | $120 |
| Exchange Rate Effect | -28 | 27 | -1 | 12 | 2 |
| Beginning Cash Position | 26,629 | 41,505 | 43,874 | 42,979 | 39,246 |
| End Cash Position | 25,264 | 26,629 | 41,505 | 43,874 | 46,938 |
| Net Cash Flow | $-15 | $-11,595 | $-3,285 | $883 | $8,928 |
| Free Cash Flow | |||||
| Operating Cash Flow | -210 | -349 | -3,175 | 790 | 8,245 |
| Free Cash Flow | -210 | -349 | -3,175 | 790 | 8,245 |